6K3K | pdb_00006k3k

Solution structure of APOBEC3G-CD2 with ssDNA, Product B


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation 3D Report Full Report

Validation slider image for 6K3K

This is version 1.3 of the entry. See complete history

Literature

Structural Investigations on the Interactions between Cytidine Deaminase Human APOBEC3G and DNA.

Yan, X.Lan, W.Wang, C.Cao, C.

(2019) Chem Asian J 14: 2235-2241

  • DOI: https://doi.org/10.1002/asia.201900480
  • Primary Citation Related Structures: 
    6K3J, 6K3K

  • PubMed Abstract: 

    Human APOBEC3G (A3G) inhibits the replication of human immunodeficiency virus-1 by deaminating cytidine at the 3'-end in the target motif 5'-CCC-3' in viral cDNA during reverse transcription. It in vitro deaminates two consecutive cytidines in a 3'->5' order. Although a crystal structure of the A3G catalytic domain (A3G-CD2) with DNA was reported, it is unknown why residues involved in enzymatic reaction are distributed widely. Here, we introduced an iodine atom into the C-5 position of cytidine (dC 6 I ) in DNA 5'-ATTC 4 C 5 C 6 I A 7 ATT-3' (TCCC 6 I ). It switches the deamination sequence preference from CCC to TCC, although small dC 6 I deamination was observed. Solution structures of A3G-CD2 in complexes with products DNA TCUC 6 I and TCUU 6 I indicate that the substrate DNA binds A3G-CD2 in TCC and CCC modes. The dC 6 deamination correlates with the 4 th base type. The CCC mode favours dC 6 deamination, while the TCC mode results in dC 5 deamination. These studies present an extensive basis to design inhibitors to impede viral evolvability.


  • Organizational Affiliation
    • State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Science, 345 Lingling Road, Shanghai, 200032, China.

Macromolecule Content 

  • Total Structure Weight: 25.33 kDa 
  • Atom Count: 1,756 
  • Modeled Residue Count: 198 
  • Deposited Residue Count: 198 
  • Unique protein chains: 1
  • Unique hybrid chains: 1

Macromolecules


Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
DNA dC->dU-editing enzyme APOBEC-3G188Homo sapiensMutation(s): 0 
Gene Names: APOBEC3G
EC: 3.5.4 (PDB Primary Data), 3.5.4.38 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for Q9HC16 (Homo sapiens)
Explore Q9HC16 
Go to UniProtKB:  Q9HC16
PHAROS:  Q9HC16
GTEx:  ENSG00000239713 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9HC16
Sequence Annotations
Expand
Reference Sequence
Find similar nucleic acids by:  Sequence
Entity ID: 2
MoleculeChains LengthOrganismImage
DNA/RNA (5'-D(*AP*TP*TP*CP*UP*(ICY)P*AP*AP*TP*T)-3')10synthetic construct
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ZN

Query on ZN



Download:Ideal Coordinates CCD File
C [auth A]ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Science Foundation (China)China21778065

Revision History  (Full details and data files)

  • Version 1.0: 2019-06-12
    Type: Initial release
  • Version 1.1: 2019-07-17
    Changes: Data collection, Database references
  • Version 1.2: 2023-06-14
    Changes: Database references, Derived calculations, Other
  • Version 1.3: 2024-05-15
    Changes: Data collection, Database references